Integrative Emergency Services

ies.healthcare

Integrative Emergency Services (IES) is transforming the way healthcare is practiced across the continuum of care and furthering the emergency department’s role in value-based healthcare delivery. IES partners with physician groups to help create a culture of excellence through leadership, research, education, knowledge translation and data-driven decision-making. IES’s high-touch approach with physician groups provides both clinical and financial benefits, resulting in EDs that deliver high-value healthcare to patients and bring value to the bottom line.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SIEMENS AND EXYTE JOIN FORCES ON MODULAR BIOTECH FACILITIES

Siemens | June 11, 2020

news image

Siemens, a process automation specialist, and Exyte, a biopharmaceutical manufacturing facility provider, have joined forces to offer end-to-end solutions for the biopharmaceutical industry.Against the background of the current challenges associated with the Covid-19 pandemic, pharmaceutical companies are facing challenges in developing and mass-producing new vaccines and medicines in existing production facilities. Siemens and Exyte are committed to tackle those challenges. Together, they...

Read More

Cell and Gene Therapy

RAPID RESHORE & DEVELOPMENT AND BRAINSTORM CELL THERAPEUTICS ANNOUNCE AGREEMENT TO ADVANCE CONSTRUCTION OF BRAINSTORM'S U.S. MANUFACTURING FACILIT

BrainStorm Cell Therapeutics | October 26, 2020

news image

Rapid Reshore & Development (RR&D), an alliance of three specialized firms, and BrainStorm Cell Therapeutics, Inc (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that BrainStorm has selected RR&D as its partner to expedite site selection and design services for a state-of-the-art manufacturing facility for NurOwn® (autologous MSC-NTF) in the U.S. BrainStorm is investigating NurOwn as a potential treatment for neurodegener...

Read More

Diagnostics

LUCID DIAGNOSTICS, A SUBSIDIARY OF PAVMED, ANNOUNCED LAUNCH OF VA ESOGUARD® STUDY

Lucid Diagnostics | March 25, 2022

news image

Lucid Diagnostics Inc., a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc, announced that investigators at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center had enrolled their first patient in a Department of Defense ("DoD")- Katarina B. Greer, M.D., an associate professor of medicine at Case Western Reserve University School of Medicine in Cleveland, is the lead investigator of the research. Lucid supplies the...

Read More

Industrial Impact

TELIX TO EXPAND LATE-STAGE UROLOGIC PIPELINE WITH ACQUISITION OF LIGHTPOINT MEDICAL

PRNewswire | June 22, 2023

news image

Telix Pharmaceuticals Limited announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a United Kingdom-based medical device company specialising in the intra-operative detection of targeted radiopharmaceuticals. SENSEI is an ultra-miniature robotic gamma probe for intracavital use that is able to provide radiopharmaceutical-based surgical guidance ("radio-guided surgery") by enabl...

Read More
news image

SIEMENS AND EXYTE JOIN FORCES ON MODULAR BIOTECH FACILITIES

Siemens | June 11, 2020

Siemens, a process automation specialist, and Exyte, a biopharmaceutical manufacturing facility provider, have joined forces to offer end-to-end solutions for the biopharmaceutical industry.Against the background of the current challenges associated with the Covid-19 pandemic, pharmaceutical companies are facing challenges in developing and mass-producing new vaccines and medicines in existing production facilities. Siemens and Exyte are committed to tackle those challenges. Together, they...

Read More
news image

Cell and Gene Therapy

RAPID RESHORE & DEVELOPMENT AND BRAINSTORM CELL THERAPEUTICS ANNOUNCE AGREEMENT TO ADVANCE CONSTRUCTION OF BRAINSTORM'S U.S. MANUFACTURING FACILIT

BrainStorm Cell Therapeutics | October 26, 2020

Rapid Reshore & Development (RR&D), an alliance of three specialized firms, and BrainStorm Cell Therapeutics, Inc (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that BrainStorm has selected RR&D as its partner to expedite site selection and design services for a state-of-the-art manufacturing facility for NurOwn® (autologous MSC-NTF) in the U.S. BrainStorm is investigating NurOwn as a potential treatment for neurodegener...

Read More
news image

Diagnostics

LUCID DIAGNOSTICS, A SUBSIDIARY OF PAVMED, ANNOUNCED LAUNCH OF VA ESOGUARD® STUDY

Lucid Diagnostics | March 25, 2022

Lucid Diagnostics Inc., a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc, announced that investigators at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center had enrolled their first patient in a Department of Defense ("DoD")- Katarina B. Greer, M.D., an associate professor of medicine at Case Western Reserve University School of Medicine in Cleveland, is the lead investigator of the research. Lucid supplies the...

Read More
news image

Industrial Impact

TELIX TO EXPAND LATE-STAGE UROLOGIC PIPELINE WITH ACQUISITION OF LIGHTPOINT MEDICAL

PRNewswire | June 22, 2023

Telix Pharmaceuticals Limited announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a United Kingdom-based medical device company specialising in the intra-operative detection of targeted radiopharmaceuticals. SENSEI is an ultra-miniature robotic gamma probe for intracavital use that is able to provide radiopharmaceutical-based surgical guidance ("radio-guided surgery") by enabl...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us